Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 71 | 2025 | 2040 | 12.060 |
Why?
|
Papillomavirus Infections | 36 | 2025 | 1638 | 6.420 |
Why?
|
Uterine Cervical Dysplasia | 20 | 2025 | 391 | 5.780 |
Why?
|
Papillomavirus Vaccines | 17 | 2023 | 495 | 5.270 |
Why?
|
Papillomaviridae | 21 | 2025 | 1137 | 3.900 |
Why?
|
Colposcopy | 15 | 2024 | 151 | 3.580 |
Why?
|
Early Detection of Cancer | 30 | 2025 | 3236 | 2.720 |
Why?
|
Alphapapillomavirus | 8 | 2022 | 219 | 2.550 |
Why?
|
Vaginal Smears | 15 | 2025 | 506 | 2.280 |
Why?
|
Practice Guidelines as Topic | 14 | 2025 | 7424 | 1.230 |
Why?
|
Cervix Uteri | 6 | 2021 | 575 | 1.190 |
Why?
|
Mass Screening | 17 | 2023 | 5445 | 1.110 |
Why?
|
Human papillomavirus 18 | 5 | 2021 | 125 | 0.690 |
Why?
|
Human papillomavirus 16 | 5 | 2021 | 268 | 0.640 |
Why?
|
Vulvar Neoplasms | 2 | 2018 | 265 | 0.630 |
Why?
|
Vaccination | 7 | 2023 | 3427 | 0.590 |
Why?
|
Vaginal Neoplasms | 1 | 2018 | 104 | 0.580 |
Why?
|
Female | 91 | 2025 | 395961 | 0.550 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 939 | 0.530 |
Why?
|
Dissection | 1 | 2017 | 299 | 0.510 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6356 | 0.500 |
Why?
|
Fluorouracil | 1 | 2017 | 1648 | 0.400 |
Why?
|
Humans | 94 | 2025 | 765734 | 0.390 |
Why?
|
Appointments and Schedules | 1 | 2015 | 444 | 0.370 |
Why?
|
Hysterectomy | 5 | 2016 | 864 | 0.360 |
Why?
|
Referral and Consultation | 4 | 2021 | 3617 | 0.360 |
Why?
|
Laser Therapy | 1 | 2017 | 1108 | 0.350 |
Why?
|
Carcinoma in Situ | 3 | 2013 | 776 | 0.350 |
Why?
|
Pregnancy | 11 | 2023 | 30248 | 0.330 |
Why?
|
Medical History Taking | 1 | 2013 | 778 | 0.320 |
Why?
|
Medical Errors | 1 | 2017 | 1259 | 0.320 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2335 | 0.320 |
Why?
|
Uterine Hemorrhage | 3 | 1995 | 235 | 0.300 |
Why?
|
Adult | 46 | 2025 | 222974 | 0.300 |
Why?
|
Gynecologic Surgical Procedures | 3 | 2023 | 287 | 0.300 |
Why?
|
Middle Aged | 43 | 2025 | 222903 | 0.290 |
Why?
|
Electrosurgery | 2 | 2021 | 53 | 0.280 |
Why?
|
Insurance Coverage | 1 | 2018 | 1945 | 0.270 |
Why?
|
Cost-Benefit Analysis | 5 | 2023 | 5526 | 0.250 |
Why?
|
Insurance, Health | 1 | 2018 | 2521 | 0.250 |
Why?
|
Precancerous Conditions | 1 | 2011 | 974 | 0.240 |
Why?
|
Massachusetts | 4 | 2018 | 8876 | 0.230 |
Why?
|
Intraoperative Complications | 2 | 2009 | 1162 | 0.220 |
Why?
|
Academic Medical Centers | 4 | 2020 | 2779 | 0.220 |
Why?
|
Young Adult | 16 | 2025 | 59852 | 0.220 |
Why?
|
Retrospective Studies | 19 | 2023 | 81457 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2017 | 9368 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2023 | 4057 | 0.200 |
Why?
|
Risk Assessment | 5 | 2022 | 24279 | 0.190 |
Why?
|
Guideline Adherence | 4 | 2025 | 2242 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3230 | 0.180 |
Why?
|
Healthcare Disparities | 4 | 2022 | 3412 | 0.180 |
Why?
|
Triage | 3 | 2022 | 996 | 0.180 |
Why?
|
Prisons | 1 | 2023 | 178 | 0.180 |
Why?
|
Cohort Studies | 12 | 2025 | 41631 | 0.170 |
Why?
|
DNA, Viral | 1 | 2006 | 2199 | 0.170 |
Why?
|
Vesicovaginal Fistula | 1 | 2019 | 10 | 0.160 |
Why?
|
Aged | 22 | 2025 | 171050 | 0.160 |
Why?
|
Neoplasms | 2 | 2018 | 22345 | 0.160 |
Why?
|
Postpartum Period | 2 | 2023 | 1200 | 0.150 |
Why?
|
United States | 13 | 2024 | 72898 | 0.150 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2018 | 22 | 0.150 |
Why?
|
Obstetrics | 2 | 2016 | 680 | 0.150 |
Why?
|
Laparotomy | 2 | 2016 | 460 | 0.150 |
Why?
|
Vulvar Diseases | 1 | 1998 | 64 | 0.150 |
Why?
|
Nutrition Surveys | 3 | 2020 | 1741 | 0.140 |
Why?
|
Fasciitis, Necrotizing | 1 | 1998 | 79 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 702 | 0.140 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 533 | 0.140 |
Why?
|
Administration, Intravaginal | 1 | 2017 | 149 | 0.140 |
Why?
|
Endometrial Hyperplasia | 2 | 1995 | 101 | 0.140 |
Why?
|
Genital Diseases, Female | 1 | 1998 | 192 | 0.140 |
Why?
|
Developing Countries | 3 | 2016 | 2912 | 0.140 |
Why?
|
Unsafe Sex | 1 | 2018 | 239 | 0.140 |
Why?
|
Endometrial Neoplasms | 3 | 1995 | 1378 | 0.130 |
Why?
|
Mouth Diseases | 1 | 2018 | 239 | 0.130 |
Why?
|
Cesarean Section | 2 | 2016 | 1431 | 0.130 |
Why?
|
Immunocompromised Host | 2 | 2018 | 863 | 0.130 |
Why?
|
Laparoscopy | 2 | 2016 | 2039 | 0.130 |
Why?
|
Menopause | 2 | 1994 | 1661 | 0.130 |
Why?
|
Health Services Administration | 1 | 2016 | 63 | 0.120 |
Why?
|
Demography | 1 | 2020 | 1641 | 0.120 |
Why?
|
Incidence | 6 | 2021 | 21478 | 0.120 |
Why?
|
Age Factors | 5 | 2018 | 18375 | 0.120 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2015 | 242 | 0.120 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2015 | 105 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2859 | 0.110 |
Why?
|
Morbidity | 2 | 2016 | 1749 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 647 | 0.110 |
Why?
|
Urban Health Services | 1 | 2014 | 176 | 0.110 |
Why?
|
Behavior Therapy | 1 | 2019 | 885 | 0.110 |
Why?
|
Adrenergic beta-Agonists | 1 | 2015 | 345 | 0.110 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 95 | 0.100 |
Why?
|
Genes, myc | 1 | 2014 | 392 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39180 | 0.100 |
Why?
|
Thromboembolism | 1 | 1999 | 1003 | 0.100 |
Why?
|
Clinical Competence | 2 | 2024 | 4862 | 0.100 |
Why?
|
Self Disclosure | 1 | 2013 | 248 | 0.100 |
Why?
|
Conization | 1 | 2011 | 18 | 0.100 |
Why?
|
Societies, Medical | 2 | 2016 | 3955 | 0.100 |
Why?
|
Endometrium | 1 | 1994 | 405 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1220 | 0.090 |
Why?
|
Rheumatic Diseases | 1 | 2018 | 622 | 0.090 |
Why?
|
Inpatients | 1 | 2023 | 2564 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2023 | 15749 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 416 | 0.090 |
Why?
|
Rural Health Services | 1 | 2014 | 393 | 0.090 |
Why?
|
Child Abuse, Sexual | 1 | 2013 | 397 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12509 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 1158 | 0.090 |
Why?
|
Health Expenditures | 1 | 2023 | 2386 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 3733 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9337 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1327 | 0.080 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2013 | 300 | 0.080 |
Why?
|
Markov Chains | 1 | 2013 | 968 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1394 | 0.080 |
Why?
|
Telomerase | 1 | 2014 | 749 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1118 | 0.080 |
Why?
|
Reoperation | 1 | 2019 | 4294 | 0.080 |
Why?
|
Medical Oncology | 2 | 2020 | 2339 | 0.080 |
Why?
|
Adolescent | 8 | 2022 | 88781 | 0.080 |
Why?
|
World Health Organization | 1 | 2014 | 1327 | 0.070 |
Why?
|
Prenatal Care | 1 | 2016 | 1157 | 0.070 |
Why?
|
Quality of Life | 2 | 2020 | 13462 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2504 | 0.070 |
Why?
|
Professional-Patient Relations | 1 | 2013 | 724 | 0.070 |
Why?
|
Photic Stimulation | 1 | 2014 | 1993 | 0.070 |
Why?
|
Biopsy | 6 | 2023 | 6754 | 0.070 |
Why?
|
Predictive Value of Tests | 5 | 2013 | 15390 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1363 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2501 | 0.070 |
Why?
|
Cryosurgery | 1 | 2011 | 479 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3272 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1998 | 2185 | 0.060 |
Why?
|
Quality-Adjusted Life Years | 1 | 2013 | 1737 | 0.060 |
Why?
|
Risk Factors | 10 | 2018 | 74831 | 0.060 |
Why?
|
Prospective Studies | 4 | 2023 | 54795 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7835 | 0.060 |
Why?
|
Postmenopause | 1 | 1994 | 2516 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3645 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2018 | 65180 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2717 | 0.060 |
Why?
|
Psychotherapy | 1 | 2013 | 1646 | 0.060 |
Why?
|
Dilatation and Curettage | 2 | 1994 | 53 | 0.060 |
Why?
|
HIV Infections | 2 | 2021 | 17531 | 0.050 |
Why?
|
Texas | 1 | 2025 | 410 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11201 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 1993 | 2002 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4038 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10069 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 949 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5506 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4763 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2839 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3926 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59459 | 0.050 |
Why?
|
Heart | 1 | 2015 | 4417 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2155 | 0.050 |
Why?
|
Male | 7 | 2024 | 363585 | 0.040 |
Why?
|
Length of Stay | 3 | 2023 | 6487 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3684 | 0.040 |
Why?
|
Angola | 1 | 2019 | 18 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4737 | 0.040 |
Why?
|
Anxiety | 1 | 2014 | 4670 | 0.040 |
Why?
|
Pain | 1 | 2014 | 5074 | 0.040 |
Why?
|
Prognosis | 3 | 2013 | 29899 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2429 | 0.040 |
Why?
|
China | 2 | 2016 | 2386 | 0.040 |
Why?
|
Time Factors | 4 | 2021 | 40066 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21053 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8038 | 0.040 |
Why?
|
Botswana | 1 | 2021 | 1057 | 0.040 |
Why?
|
Vulva | 1 | 2018 | 84 | 0.040 |
Why?
|
Patient Preference | 2 | 2016 | 952 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13448 | 0.030 |
Why?
|
Condoms | 1 | 2018 | 336 | 0.030 |
Why?
|
Dental Care | 1 | 2019 | 286 | 0.030 |
Why?
|
Polynesia | 1 | 2016 | 14 | 0.030 |
Why?
|
Algorithms | 2 | 2014 | 14061 | 0.030 |
Why?
|
Debridement | 1 | 1998 | 494 | 0.030 |
Why?
|
Rats, Zucker | 1 | 2015 | 129 | 0.030 |
Why?
|
Maternal Mortality | 1 | 1998 | 311 | 0.030 |
Why?
|
Risk | 2 | 2005 | 9592 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3067 | 0.030 |
Why?
|
Isoproterenol | 1 | 2015 | 398 | 0.030 |
Why?
|
Propionates | 1 | 2015 | 180 | 0.030 |
Why?
|
Echocardiography, Stress | 1 | 2015 | 137 | 0.030 |
Why?
|
Professional Practice | 1 | 2016 | 313 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5368 | 0.030 |
Why?
|
HIV | 1 | 2021 | 1585 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3805 | 0.030 |
Why?
|
Psychotherapeutic Processes | 1 | 2013 | 50 | 0.030 |
Why?
|
Reminder Systems | 1 | 2016 | 388 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15833 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 13079 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2653 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14637 | 0.030 |
Why?
|
Odds Ratio | 2 | 2014 | 9647 | 0.020 |
Why?
|
Logistic Models | 2 | 2019 | 13261 | 0.020 |
Why?
|
Pelvis | 1 | 2016 | 738 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1208 | 0.020 |
Why?
|
Signal Transduction | 1 | 2015 | 23589 | 0.020 |
Why?
|
Clinical Coding | 1 | 2013 | 188 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12056 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 514 | 0.020 |
Why?
|
Psychological Tests | 1 | 2013 | 643 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20120 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1259 | 0.020 |
Why?
|
Office Visits | 1 | 1994 | 594 | 0.020 |
Why?
|
Robotics | 1 | 2016 | 808 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6499 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5302 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2015 | 1516 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 769 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11007 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2425 | 0.020 |
Why?
|
Rats | 2 | 2015 | 23704 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2910 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1810 | 0.020 |
Why?
|
Terminal Care | 1 | 2020 | 1774 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 667 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3595 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2611 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3432 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1175 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22224 | 0.020 |
Why?
|
Life Expectancy | 1 | 1993 | 1248 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10605 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1670 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1458 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26284 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3451 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5019 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10385 | 0.010 |
Why?
|
Anticoagulants | 1 | 1999 | 4862 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6018 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8293 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8703 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12949 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2649 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3772 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5765 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12787 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4207 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14745 | 0.010 |
Why?
|
Hospitalization | 1 | 1998 | 10806 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7599 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8062 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2013 | 4862 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8730 | 0.010 |
Why?
|
Animals | 2 | 2015 | 168731 | 0.010 |
Why?
|
Child | 1 | 2013 | 80499 | 0.000 |
Why?
|